Optiver Holding B.V. Genfit S.A. Transaction History

Optiver Holding B.V.

$2.38 Billion
Q1 2024

A detailed history of Optiver Holding B.V. transactions in Genfit S.A. stock. As of the latest transaction made, Optiver Holding B.V. holds 963 shares of GNFT stock, worth $3,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

963

Previous 82,359 98.83%

Holding current value

$3,476

Previous $317,000 99.05%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$3.34 - $4.04 $271,862 - $328,839	-81,396 Reduced 98.83%	963 $3,000
Q4 2023 Feb 13, 2024	BUY	$2.97 - $3.94 $234,104 - $310,562	78,823 Added 2229.16%	82,359 $317,000
Q3 2023 Nov 13, 2023	SELL	$3.15 - $4.12 $923,189 - $1.21 Million	-293,076 Reduced 98.81%	3,536 $11,000
Q2 2023 Aug 10, 2023	BUY	$3.54 - $4.68 $955,003 - $1.26 Million	269,775 Added 1005.24%	296,612 $1.05 Million
Q1 2023 May 11, 2023	BUY	$3.93 - $4.69 $12,414 - $14,815	3,159 Added 13.34%	26,837 $110,000

Q4 2022 Feb 10, 2023	BUY	$3.53 - $4.39 $20,985 - $26,098	5,945 Added 33.53%	23,678 $103,000
Q3 2022 Nov 14, 2022	SELL	$3.26 - $4.86 $66,908 - $99,746	-20,524 Reduced 53.65%	17,733 $65,000
Q2 2022 Aug 10, 2022	SELL	$3.09 - $4.25 $7,527 - $10,353	-2,436 Reduced 5.99%	38,257 $123,000
Q1 2022 May 16, 2022	BUY	$3.14 - $5.04 $117,005 - $187,805	37,263 Added 1086.38%	40,693 $163,000
Q4 2021 Feb 14, 2022	BUY	$3.01 - $5.65 $4,828 - $9,062	1,604 Added 87.84%	3,430 $17,000
Q3 2021 Nov 15, 2021	BUY	$3.58 - $4.14 $6,537 - $7,559	1,826 New	1,826 $7,000
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.63 $155,473 - $189,431	-40,914 Closed	0 $0
Q1 2021 May 20, 2021	SELL	$4.53 - $6.06 $814,919 - $1.09 Million	-179,894 Reduced 81.47%	40,914 $189,000
Q1 2021 May 14, 2021	BUY	$4.53 - $6.06 $1 Million - $1.34 Million	220,808 New	220,808 $1.02 Million

Others Institutions Holding GNFT

# of Institutions

Shares Held

76.8K

Call Options Held

Put Options Held

View Full List

About Genfit S.A.

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $180M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

More about GNFT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.

Account

Optiver Holding B.V. Genfit S.A. Transaction History